PMC:7105881 / 25813-26043 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"766","span":{"begin":9,"end":17},"obj":"Species"}],"attributes":[{"id":"A766","pred":"tao:has_database_id","subj":"766","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T111","span":{"begin":20,"end":27},"obj":"Body_part"},{"id":"T112","span":{"begin":86,"end":94},"obj":"Body_part"},{"id":"T113","span":{"begin":194,"end":201},"obj":"Body_part"}],"attributes":[{"id":"A111","pred":"fma_id","subj":"T111","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A113","pred":"fma_id","subj":"T113","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T110","span":{"begin":9,"end":17},"obj":"Disease"}],"attributes":[{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T272","span":{"begin":36,"end":44},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T273","span":{"begin":122,"end":129},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_33208"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T117","span":{"begin":20,"end":27},"obj":"Chemical"},{"id":"T118","span":{"begin":36,"end":44},"obj":"Chemical"},{"id":"T119","span":{"begin":194,"end":201},"obj":"Chemical"}],"attributes":[{"id":"A117","pred":"chebi_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A119","pred":"chebi_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T154","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T500","span":{"begin":9,"end":17},"obj":"SP_10"},{"id":"T501","span":{"begin":18,"end":27},"obj":"PG_3"},{"id":"T502","span":{"begin":50,"end":64},"obj":"BV_15"},{"id":"T503","span":{"begin":86,"end":94},"obj":"GO:0042571"},{"id":"T504","span":{"begin":122,"end":129},"obj":"NCBITaxon:33208"},{"id":"T81541","span":{"begin":9,"end":17},"obj":"SP_10"},{"id":"T69900","span":{"begin":18,"end":27},"obj":"PG_3"},{"id":"T5444","span":{"begin":50,"end":64},"obj":"BV_15"},{"id":"T28747","span":{"begin":86,"end":94},"obj":"GO:0042571"},{"id":"T58051","span":{"begin":122,"end":129},"obj":"NCBITaxon:33208"}],"text":"Notably, SARS-CoV M protein-derived peptides have immunogenicity to induce high-titer antibody responses in the immunized animals (He et al., 2005b), suggesting the potential for utilizing this protein to develop subunit vaccines."}